Skip to main content
PMC home page
Springer logoLink to Springer
. 2020 May 8;313(3):139–146. doi: 10.1007/s00403-020-02083-0

Protective effects of a comprehensive topical antioxidant against ozone-induced damage in a reconstructed human skin model

Alessandra Pecorelli 1, David H McDaniel 2, Mitchell Wortzman 3, Diane B Nelson 3,✉
PMCID: PMC7935815  PMID: 32385690

Abstract

Tropospheric ozone (O3) is a source of oxidative stress. This study examined the ability of a topical antioxidant (WEL-DS) to inhibit O3-mediated damage in a human epidermal skin model. Four groups of tissues (N = 24) were compared: Group 1 (control) were untreated and unexposed; Group 2 were untreated and exposed to O3 (0.4 ppm, 4 h); Group 3 were pretreated with WEL-DS and unexposed; Group 4 were pretreated with WEL-DS and exposed to O3 (0.4 ppm, 4 h). Pretreated tissues were topically treated with 20 uL of WEL-DS and incubated for up to 20 h at 37 °C [humidified, 5% carbon dioxide (CO2)]. After 24 h, tissues were re-treated with WEL-DS and exposed to O3. Tissues were evaluated for Reactive Oxygen Species (ROS), hydrogen peroxide (H2O2), 4-hydroxynonenal (4-HNE) protein adducts, NF-κB p65 response and histology. In O3-exposed groups, WEL-DS significantly inhibited ROS formation vs. untreated tissues (p < 0.05). Pretreatment with WEL-DS inhibited H2O2 production vs. untreated tissues (p < 0.05), and decreased NF-κB p65 transcription factor signal. Oxidative stress induction in O3-exposed tissues was confirmed by increased levels of 4-HNE protein adducts (marker of lipid peroxidation); WEL-DS application reduced this effect. WEL-DS inhibited damage in tissues exposed to O3 with no significant changes in epidermal structure. A comprehensive topical antioxidant significantly diminished O3-induced oxidative damage in a human epidermal skin model.

Keywords: Antioxidants, Ozone, Oxidative damage, Cosmeceuticals, Free radicals, Reactive Oxygen Species (ROS)

Introduction

Skin provides a protective barrier against radiation from ultraviolet (UV) exposure and other external environmental stressors, and has a natural ability to protect itself against the effects of aging, harmful UV radiation, and exposure to other environmental factors such as ozone (O3) through an elaborate antioxidant defense system [1–9]. These external environmental stressors generate free radicals that, coupled with intrinsic aging, can overwhelm the skin’s natural endogenous defenses, causing oxidative damage [1, 2, 8–10]. As skin loses its ability to function efficiently, this leads to suboptimal protection against infection, cancer, as well as accelerated skin aging [1, 2, 8, 9, 11, 12].

Tropospheric O3 is produced by chemical reactions between oxygen and air pollutants in the presence of sunlight. Lungs and skin are the main target organs directly exposed to tropospheric O3. It does not penetrate the deeper layers of skin, but acts via oxidative stress and inflammation [13]. Ozone is not a radical species per se; rather, it is a highly reactive pollutant that depletes endogenous antioxidants, triggering a cellular response and generating free radicals that lead to lipid peroxidation [13–15]. Among the by-products of lipid peroxidation are the alpha–beta unsaturated aldehyde 4-hydroxynonenal (4-HNE) and isoprostanes like 8-iso-prostaglandin-f(2α) [13, 16]. 4-HNE is a recognized marker of oxidative stress and important in mediating various signaling pathways [16]. In addition, oxidative stress from O3 can activate redox-sensitive transcription factors, particularly NF-κB [13], triggering inflammatory responses. Furthermore, O3 has been shown to influence the activity of enzymes involved in the turnover and degradation of connective tissue, such as expression of metalloproteinase (MMP)-9 [13]. These molecular mechanisms induced by a cumulative exposure to O3 lead to tissue damage and compromise skin barrier integrity.

Sunscreens protect skin against damage caused by exposure to UVA and UVB radiation by absorbing, blocking and scattering UV, but mechanistically do not have the ability to protect against damage caused by free radicals. Through the generation of free radicals and Reactive Oxygen Species (ROS), O3 depletes antioxidant levels in the skin. Topical antioxidants penetrate the skin to neutralize free radicals, preventing damage to cells [17–19]. Thus, topical antioxidants can potentially protect against O3-induced skin damage and enhance skin’s natural antioxidant defenses [19–24]. As such, topical antioxidants act as an additional safety net to sunscreens [17, 19, 23].

Topical antioxidants provide unique properties and benefits in combating free radicals depending upon their source. Hydrophilic (water-soluble) antioxidants protect the water-containing portions of cells, interior cell structures, and interstitial fluid [20, 21]. Enzymatic antioxidants such as superoxide dismutase and ubiquinone support the body’s internal defenses and protect mitochondria. Lipid-rich components of cells, including cell membranes, are protected by hydrophobic or lipid-soluble antioxidants, such as vitamin E [20, 21]. Developing an effective multi-sourced topical antioxidant is challenging owing to the inherent chemical instability of antioxidants [22].

Comprehensive skin protection requires a topical product that combines various antioxidants to facilitate synergistic interaction and provide broad-based protection from various types of ROS across all cellular levels of the skin [19, 25, 26]. Developed utilizing advanced formulating chemistry techniques, WEL-DS, a comprehensive topical antioxidant, combines a balanced ratio of 19 potent water-soluble, enzymatic, and lipid-soluble antioxidants, designed to provide broad-range protection of the skin from free radical damage (Table 1). Prior studies have demonstrated WEL-DS’s ability to quench free radicals, protect skin from the oxidizing effects of UV radiation, and visibly reduce the effects of facial photodamage [27].

Table 1.

WEL-DS antioxidant ingredients

Water-soluble antioxidants Enzymatic antioxidants Lipid-soluble antioxidants
Chlorogenic acids Arabidopsis thaliana extract Tetrahexyldecyl ascorbate (vitamin C)
Coffea arabica leaf extract Superoxide Dismutase (SOD)a Tocopheryl acetate/tocopherol (vitamin E)
Theobroma cacao seed extract (cocoa) Ubiquinone (CoEnzyme Q10)b

Glycyrrhiza glabra root extract

(licorice)
Ergothioneine Ubiquinone (CoEnzyme Q10)b

Curcuma longa root extract

(turmeric)
Euterpe oleracea fruit extract (acai)

Vitis vinifera seed extract

(grape seed)
Buddleja officinalis flower extract
Camellia sinensis leaf extract (green tea)
Carnosine

Crocus sativus leaf extract

(saffron)
Olea europaea fruit extract (olive)
Superoxide dismutase (SOD)a
Open in a new tab

aAntioxidants that are both water-soluble and enzymatic

bAntioxidants that are both lipid-soluble and enzymatic

The study described herein evaluated the ability of WEL-DS to protect skin against O3-mediated damage utilizing a reconstructed human epidermal skin model.

Materials and methods

Reconstructed human epidermal skin model and experimental design

Reconstructed human epidermal skin tissues (EpiDerm™ model, MatTek Corporation, Ashland MA) were incubated at 37 °C and 5% CO2 overnight. Tissues were then divided into four groups, each containing six tissue samples (N = 24): Group 1 tissues served as an untreated, unexposed control; Group 2 tissues were untreated and exposed to 0.4 parts per million (ppm) of O3 for 4 h; Group 3 tissues were pretreated with WEL-DS and unexposed, and Group 4 tissues were pretreated with WEL-DS and exposed to 0.4 ppm of O3 for 4 h.

WEL-DS pretreatment and O3 exposure

Pretreated tissues in Groups 3 and 4 were topically treated with 20 µL of WEL-DS and incubated for up to 20 h at 37 °C in a humidified 5% CO2 atmosphere. Following overnight treatment, the tissues were treated with a second application of WEL-DS and exposed to 0.4 ppm of O3 (Groups 2 and 4) or filtered air (Groups 1 and 3) for 4 h.

Ozone was generated from O2 by an electrical corona arc discharge generator (Model 306 ozone Calibration Source, 2B Technologies, Ozone Solution USA). The O2–O3 mixture (95% O2, 5% O3) was combined with ambient air and introduced into a Teflon-lined exposure chamber, continuously ventilated. O3 concentration in the chamber was adjusted to 0.4 ppm at the input of the circuit and continuously monitored by an O3 detector at the output port of the circuit. Exposure to filtered air was carried out in a similar exposure chamber. Temperature and humidity were monitored during exposures.

Measurement of intracellular ROS levels

After the second application of WEL-DS and before O3 exposure, a part of tissues (N = 3 per condition) were incubated in the dark with 340 μM 2′,7′-dichlorofluorescein diacetate (DCF-DA) in DPBS for 30 min at 37 °C in a humidified 5% CO2 atmosphere, to determine intracellular ROS levels. Then, tissues were rinsed with DPBS, placed in a new plate with culture medium and exposed to O3 0.4 ppm for 4 h. At the end of O3 exposure, DCF fluorescence, a measure of ROS production, was determined by SpectraMax iD3 plate reader (Molecular Devices, LLC., San Jose, CA, USA), at 485 nm (excitation filter) and 530 nm (emission filter).

Hydrogen peroxide (H2O2) production

The levels of H2O2 in the media were evaluated by the Amplex Red-Horseradish Peroxidase (HRP) method. Amplex Red reacts with H2O2 in an HRP-catalyzed reaction, producing highly fluorescent resorufin. Briefly, at the end of the O3 exposure (4 h), 10 μl of maintenance medium from each tissue was added to a 96-well plate and, then, a working solution containing 25 µM Amplex Red reagent and 0.5 U/ml HRP were added to each well. After 30 min incubation in the dark, fluorescence was detected with a Synergy H1 Hybrid Multi-Mode Reader (BioTek Instruments, Inc., Winooski, VT, US) with excitation/emission wavelengths of 530 nm/590 nm. H2O2 accumulation in the medium was calculated by comparing its fluorescence with that of an H2O2 standard curve. H2O2 production was expressed in micromolar units.

4-Hydroxynonenal (4-HNE) protein adducts levels

Following O3 exposure, tissues (N = 3 per condition) were placed at 37 °C in the 5% CO2 incubator overnight. After 24 h, tissues were rinsed several times with DPBS and then incubated with 0.02% trypsin/EDTA for 2 min at 37 °C, and washed again with DPBS. Then, tissues were snap-frozen in liquid nitrogen and homogenized in a lysis T-PER buffer containing 1% protease inhibitors and 1% phosphatase inhibitors. After centrifugation at 17,115g at 4 °C, the supernatants were collected and protein concentration was measured by Bradford assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Levels of 4-HNE protein adduct in tissue lysates were measured using an ELISA kit (OxiSelect™ HNE-His Adduct ELISA kit, Cell Biolabs, Inc., San Diego, CA), according to the manufacturer’s instructions. The content of 4-HNE protein adducts was spectrophotometrically evaluated at 450 nm and expressed in µg/mg protein.

Histological analysis and immunofluorescence

General morphological structure of different epidermal layers in tissues were analyzed using hematoxylin and eosin (H&E) staining. In addition, the NF-κB pathway was evaluated by immunofluorescence for p65 subunit. As previously described, following O3 exposure, tissues (N = 3 per condition) were placed at 37 °C in the 5% CO2 incubator overnight. After 24 h, tissues were fixed by immersion in 10% neutral-buffered formalin (NBF) at RT and then paraffin embedded. Sections (4 μm) were deparaffinized in xylene and rehydrated in alcohol gradients, before H&E staining or immunofluorescence analysis. For immunofluorescence, after a heat-mediated antigen retrieval step in pH 6.0 citrate buffer, tissues were blocked in 5% normal goat serum for 1 h and, then, incubated with NF-κB p65 antibody overnight at 4 °C. Slides were then incubated with a secondary fluorescent goat anti-rabbit Alexa Fluor 488 antibody for 1 h at RT in the dark. The slides were mounted with ProLong Gold Antifade Mountant with 4′, 6-diamidino-2-phenylindole (DAPI) for nuclei staining. Negative control sections were processed by omitting primary antibody. Images were acquired using a Zeiss Z1 AxioObserver LSM10 confocal microscope equipped at 40 × magnification.

Statistical analysis

Statistical analyses were performed using GraphPad Prism software (GraphPad Software, La Jolla, CA). Results were expressed as mean value ± SD. Data among multiple groups were compared using two-way ANOVA, followed by Tukey’s post hoc test for multiple comparisons. Differences were considered statistically significant if p < 0.05, p < 0.01, or p < 0.001.

Results

Intracellular ROS production

As determined by DCF-DA assay, exposure to 0.4 ppm of O3 induced a significant increase of ROS production in untreated exposed tissues compared to air-exposed tissues (p < 0.05; Fig. 1). Application of WEL-DS significantly reduced ROS formation in pretreated tissues exposed to O3 compared with tissues that were untreated and exposed to O3 (p < 0.05; Fig. 1).

Fig. 1.

Fig. 1

Open in a new tab

Pretreatment with WEL-DS inhibited ROS production in O3-exposed tissues (*p < 0.05)

H2O2 formation

A specific and commonly known ROS, H2O2, was evaluated. As seen in Fig. 2, there was a significant increase of H2O2 after 4 h of O3 exposure in untreated tissues compared to air-exposed tissues (p < 0.01 and p < 0.001), significantly different from untreated and WEL-DS-treated tissues, respectively. In O3-exposed tissues, topical pretreatment with WEL-DS decreased H2O2 production compared to untreated tissues (p < 0.001; Fig. 2).

Fig. 2.

Fig. 2

Open in a new tab

Pretreatment with WEL-DS inhibited H2O2 formation in O3-exposed tissues (**p < 0.01 and ***p < 0.001)

4-HNE protein adducts levels

Evidence of induction of oxidative stress in tissues exposed to O3 was confirmed by increased levels of 4-HNE protein adducts, a marker of lipid peroxidation and protein oxidative damage. Twenty hours following O3 exposure, there was a significant increase in 4-HNE protein adducts in untreated exposed tissues compared to air-exposed tissues (p < 0.001; Fig. 3). In O3-exposed tissues, pretreatment with WEL-DS significantly reduced this effect compared to untreated, O3-exposed tissues (p < 0.01).

Fig. 3.

Fig. 3

Open in a new tab

WEL-DS reduced the formation of 4-HNE protein adducts in O3-exposed tissues (**p < 0.01 and ***p < 0.001)

NF-κB p65 protein expression

The ability of O3 exposure to induce inflammatory signaling pathways in the skin is well known [13]. To test the effect of WEL-DS to inhibit inflammatory responses triggered by O3, NF-κB p65 expression was evaluated in tissues by immunofluorescence. As indicated by the enhanced green fluorescence signal in Fig. 4b, there was an increase in NF-κB p65 protein in skin tissues exposed to O3. Of note, pretreatment with WEL-DS was able to prevent this effect, as noticed by the lower intensity of NF-κB p65 green signal in tissues pretreated and exposed to O3 (Fig. 4d). No difference in NF-κB p65 protein expression was observed in control tissues (Fig. 4a, c).

Fig. 4.

Fig. 4

Open in a new tab

Pretreatment with WEL-DS prevented the increase in NF-κB protein expression (green fluorescence), following exposure to O3. a Air. b O3 exposure. c WEL-DS. d WEL-DS + O3 exposure. Nuclei (blue) were stained with DAPI. Original magnification ×40

Histopathologic examination

Histopathological examination demonstrated the protective effects of WEL-DS on epidermal tissues exposed to O3 (Fig. 5a–d). Morphological alterations were observed in untreated tissues exposed to O3 with tissues appearing separated and disorganized (Fig. 5c). Conversely, WEL-DS inhibited tissue damage in pretreated tissues exposed to O3 with no significant changes in epidermal structure with the epidermis remaining intact and compact in appearance, similar to that of the unexposed control (Fig. 5a, d, respectively).

Fig. 5.

Fig. 5

Open in a new tab

Pretreatment with WEL-DS inhibited structural damage in O3-exposed tissues. a Normal control—no O3 exposure. b WEL-DS—no O3 exposure. c Untreated + O3 exposure. d WEL-DS + O3 exposure

Discussion

Tropospheric O3 is one of the most toxic environmental stressors to skin. Research using an in vivo skin model demonstrated an increase of proliferative, adaptive and pro-inflammatory cutaneous tissue responses to O3 exposure [28]. Upon interaction with the lipid-rich plasma membrane of the skin barrier, O3 exposure generates free radicals that initiate a lipid peroxidation reaction cascade [29]. ROS stimulate the release of pro-inflammatory mediators, leading to changes that generate more free radicals in a vicious cycle [29]. Ozone depletes levels of antioxidants in the stratum corneum and, thus, damages barrier function, also causing a series of cellular stress responses in the deeper layers of the skin [15]. This results in the production of 4-HNE, a marker of oxidative stress and lipid peroxidation that forms protein adducts associated with a variety of negative consequences to skin [30–32]. As reported in this study, pretreatment with WEL-DS significantly inhibited the formation of 4-HNE protein adducts following O3 exposure.

Through complex biological processes, oxidative stress leads to transient or permanent damage and activation of redox-sensitive transcription factors and signaling pathways involved in cell growth and differentiation as well as degradation of connective dermal tissue [29]. One of the most well studied of these is NF-κB. Activation of NF-κB involves the dissociation of the cytosolic NF-κB/IκB complex, which allows NF-κB to translocate into the nucleus, where it binds to its DNA recognition sequence and initiates gene transcription for several mediators such as growth factors and pro-inflammatory cytokines. Pretreatment with WEL-DS prevented the increase in NF-κB protein expression following O3 exposure; this may be an indicator of WEL-DS’s ability to inhibit O3-induced pro-inflammatory responses. Further investigation is needed to address this hypothesis.

Early research demonstrated that increasing exposure to O3 depletes levels of vitamins E and C in the skin [33]. More recent studies have shown that continued exposure to O3 is associated with an increased risk of skin conditions such as urticaria, eczema, and contact dermatitis [34–36]. Ground level O3 varies by location and other environmental pollutants; the concentration can range from 0.2 to 1.2 ppm in urban environments [37]. In this study, skin was exposed to O3 at 0.4 ppm. Ozone at 0.5 ppm is the level at which Los Angeles declares a Smog Alert No. 1. While sunscreens afford substantial benefit in protecting skin against UVA and UVB radiation, sunscreens alone offer no protection against the effects of O3 and other environmental elements. Sunscreens scatter, absorb, or block UV radiation prior to the formation of free radicals in the skin; topical antioxidants can penetrate the skin providing deeper protection [38]. Antioxidants neutralize free radicals and inhibit their capacity to inflict cellular damage. Exposure to O3 depletes antioxidants (such as vitamin E) in the skin; topical application of antioxidants can replenish antioxidant levels in the skin and protect the skin from O3-induced damage [13, 14, 33, 38]. Consequently, topical antioxidants assume a complementary role to sunscreens in providing optimal and comprehensive skin protection [17, 19, 23].

Previous research performed in a reconstructed human epidermal model investigated the ability of antioxidant mixtures containing vitamins C and/or E in preventing the deleterious effects of O3 on skin. Results demonstrated that pretreatment with the antioxidant mixtures reduced O3-induced oxidative stress [31].

Prior studies have demonstrated the benefits of WEL-DS in protecting skin against damage from UVA and UVB radiation [27]. An initial study evaluated the antioxidant capacity of WEL-DS in comparison to a leading antioxidant serum (L-AOX) and saline in human skin explants exposed to oxidative stress in two independent tests. A standardized hydrogen peroxide assay kit was used to detect peroxide activity in washed, homogenized skin tissue (20 µL of 0.1 mM hydrogen peroxide was used for each graft). Relative reduction in oxidative stress versus control was compared between WEL-DS and L-AOX. WEL-DS and L-AOX demonstrated significant antioxidant capacity in neutralizing hydrogen peroxide in human skin compared to saline; notably, skin treated with WEL-DS neutralized 53% and 41% increases in oxidative stress for L-AOX (test 1 and test 2, respectively). When tests were combined, mean oxidative stress over time was 33% significantly greater for L-AOX compared to WEL-DS (p = 0.012), indicating WEL-DS’s ability to quench hydrogen peroxide in comparison to saline and a leading antioxidant serum.

A second study assessed the ability of WEL-DS to protect skin against the oxidizing effects of UV radiation compared to an untreated, irradiated site in healthy women [27]. Compared to untreated, irradiated skin, pretreatment with WEL-DS led to significant reductions in UV-induced erythema at all minimal erythema dose (MED) exposures (1× MED, p = 0.025; 2× MED, p < 0.001; 3× MED, p = 0.004). Skin treated with WEL-DS also demonstrated significant reductions in thymine dimer formation (p < 0.02) and the upregulation of MMP-9 (p < 0.005). Skin pretreated with WEL-DS revealed substantial reductions in UV-stimulated sunburn cells and p53, in addition to significant protective effects to Langerhans Cells (p < 0.008) versus untreated skin.

A clinical trial evaluated the effectiveness and tolerability of WEL-DS for improvement in the appearance of facial aging caused by environmental or photodamage [27]. Twenty-two female subjects with mild to moderate facial photoaging were enrolled in this 12-week clinical study; 14 subjects were evaluated through 16 weeks. WEL-DS demonstrated visible improvements from baseline for fine lines/wrinkles (37%), erythema (18%), skin tone (17%), dyschromia (13%), and pore size (4%), with continued, progressive improvements achieved in all categories from baseline through week 16 in a subset of subjects. WEL-DS was well tolerated throughout the duration of the study.

Results from the present study provide additional support regarding the protective benefits of combinations of topical antioxidants against O3-induced damage to the skin. In the current study, pretreatment with a topical antioxidant serum containing a balanced ratio of 19 antioxidants designed to provide broad-based protection against free radical damage to skin significantly inhibited production of ROS, prevented the formation of hydrogen peroxide, and inhibited the formation of 4-HNE protein adducts in ozone-exposed tissues. Pretreatment with WEL-DS also inhibited structural damage and prevented the induction of NF-κB p65 protein in skin model tissues exposed to O3. Together, these findings demonstrate that WEL-DS is able to neutralize the effects of oxidative stress caused by O3 exposure.

In summary, application of a comprehensive topical antioxidant serum containing water-soluble, enzymatic, and lipid-soluble antioxidants, significantly diminished the effects of O3-induced oxidative damage in a reconstructed human epidermal skin model, suggesting that WEL-DS exhibits protective effects against daily O3 pollutant exposure.

Acknowledgements

We would like to thank Lynne Kolton Schneider, PhD, for her editorial assistance on this manuscript.

Abbreviations

O3

Tropospheric ozone

ROS

Reactive oxygen species

H2O2

Hydrogen peroxide

4-HNE

4-Hydroxynonenal

NF-κB

Nuclear factor kappa-light chain enhancer of activated B cells

UV

Ultraviolet

MMP

Metalloproteinase

CO2

Carbon dioxide

Ppm

Parts per million

DCF-DA

Dichlorodihydrofluorescein diacetate

HRP

Horseradish peroxidase

NBF

Neutral-buffered formalin

L-AOX

Leading antioxidant

MED

Minimal erythema dose

Author contributions

AP: conceptualization, data curation, formal analysis, funding acquisition, investigation, methodology, project administration, resources, software, supervision, validation, visualization, writing—original draft preparation, writing—review and editing. DM: conceptualization. MW: conceptualization. DN: conceptualization, project administration.

Funding

This study was funded by skinbetter science, LLC.

Compliance with ethical standards

Conflict of interest

Dr. Alessandra Pecorelli, an employee of NC State University, Plants for Human Health Institute, was an investigator in this study. Dr. McDaniel served as a consultant to skinbetter science on the design of this study. Dr. Wortzman and Ms. Nelson are employees of skinbetter science. Dr. Pecorelli has no conflict of interest relevant to the content of this article.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Alessandra Pecorelli, Email: apecore@ncsu.edu.

David H. McDaniel, Email: dhm@miaar.com

Mitchell Wortzman, Email: mitch.wortzman@dermaforce.com.

Diane B. Nelson, Email: diane.nelson@skinbetter.com

References

  • 1.Allemann IB, Baumann L. Antioxidants used in skin care formulations. Skin Therapy Lett. 2008;13(7):5–9. [PubMed] [Google Scholar]
  • 2.Burke KE. Protection from environmental skin damage with topical antioxidants. Clin Pharmacol Ther. 2019;105(1):36–38. doi: 10.1002/cpt.1235. [DOI] [PubMed] [Google Scholar]
  • 3.Chen L, Hu JY, Wang SQ. The role of antioxidants in photoprotection: a critical review. J Am Acad Dermatol. 2012;67(5):1013–1024. doi: 10.1016/j.jaad.2012.02.009. [DOI] [PubMed] [Google Scholar]
  • 4.Lotito SB, Frei B. Relevance of apple polyphenols as antioxidants in human plasma: contrasting in vitro and in vivo effects. Free Radic Biol Med. 2004;36(2):201–211. doi: 10.1016/j.freeradbiomed.2003.10.005. [DOI] [PubMed] [Google Scholar]
  • 5.Murray JC, Burch JA, Iannacchione MA, Pinnell SR. A topical antioxidant solution containing vitamins C and E with ferulic acid protects human skin from sunlight damage and DNA mutations associated with skin cancer. J Invest Dermatol. 2007;127:S134. [Google Scholar]
  • 6.Ou S, Kwok KC. Ferulic acid: pharmaceutical functions, preparation and applications in foods. J Sci Food Agric. 2004;84:1261–1269. doi: 10.1002/jsfa.1873. [DOI] [Google Scholar]
  • 7.Pinnell SR. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol. 2003;48:1–19. doi: 10.1067/mjd.2003.16. [DOI] [PubMed] [Google Scholar]
  • 8.Poljšak B, Dahmane R. Free radicals and extrinsic skin aging. Dermatol Res Pract. 2012;2012:135206. doi: 10.1155/2012/135206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Poljšak B, Dahmane RG, Godić A. Intrinsic skin aging: the role of oxidative stress. Acta Dermatovenerologica. 2012;21:33–36. [PubMed] [Google Scholar]
  • 10.Stojilijković D, Pavlović D, Arsić I. Oxidative stress, skin aging and antioxidant therapy. Scientific J Fac Med Niš. 2014;31(4):207–217. [Google Scholar]
  • 11.Hozier AM, Athar M, Elmets CA. The other end of the rainbow: infrared and skin. J Invest Dermatol. 2010;130(6):1496–1499. doi: 10.1038/jid.2010.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sander CS, Chang H, Salzmann S, et al. Photoaging is associated with protein oxidation in human skin in vivo. J Investig Dermatol. 2002;118(4):618–625. doi: 10.1046/j.1523-1747.2002.01708.x. [DOI] [PubMed] [Google Scholar]
  • 13.Valacchi G, Pecorelli A, Belmonte G, et al. Protective effects of topical vitamin C compound mixtures against ozone-induced damage in human skin. J Investig Dermatol. 2017;137:1373–1375. doi: 10.1016/j.jid.2017.01.034. [DOI] [PubMed] [Google Scholar]
  • 14.Burke KE. Mechanisms of aging and development—A new understanding of environmental damage to the skin and prevention with topical antioxidants. Mech Ageing Dev. 2018;172:123–130. doi: 10.1016/j.mad.2017.12.003. [DOI] [PubMed] [Google Scholar]
  • 15.Valacchi G, Sticozzi C, Belmonte G, et al. Vitamin C compound mixtures prevent ozone-induced oxidative damage in human keratinocytes as initial assessment of pollution protection. PLoS ONE. 2015;10(8):e0131097. doi: 10.1371/journal.pone.0131097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zhong H, Yin H. Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria. Redox Biology. 2015;4:193–199. doi: 10.1016/j.redox.2014.12.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Oresajo C, Stephens T, Hino PD, et al. Protective effects of a topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin against ultraviolet-induced photodamage in human skin. J Cosmet Dermatol. 2008;7(4):290–297. doi: 10.1111/j.1473-2165.2008.00408.x. [DOI] [PubMed] [Google Scholar]
  • 18.Pinnell SR, Yang H, Omar M, et al. Topical l-ascorbic acid: percutaneous absorption studies. Dermatol Surg. 2001;27(2):137–142. doi: 10.1046/j.1524-4725.2001.00264.x. [DOI] [PubMed] [Google Scholar]
  • 19.Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interventions Aging. 2007;2(2):219–236. [PMC free article] [PubMed] [Google Scholar]
  • 20.Abla MJ, Banga AK. Quantification of skin penetration of antioxidants of varying lipophilicity. Int J Cosmet Sci. 2013;35(1):19–26. doi: 10.1111/j.1468-2494.2012.00728.x. [DOI] [PubMed] [Google Scholar]
  • 21.Alonso C, Rubio L, Touriño S, et al. Antioxidative effects and percutaneous absorption of five polyphenols. Free Radic Biol Med. 2014;75:149–155. doi: 10.1016/j.freeradbiomed.2014.07.014. [DOI] [PubMed] [Google Scholar]
  • 22.Hatem S, Nasr M, Elkheshen SA, Geneidi AS. Recent advances in antioxidant cosmeceutical topical delivery. Curr Drug Deliv. 2018;15(7):953–964. doi: 10.2174/1567201815666180214143551. [DOI] [PubMed] [Google Scholar]
  • 23.Mayoral FA, Kenner JR, Draelos ZD. The skin health and beauty pyramid: a clinically based guide to selecting topical skincare products. J Drugs Dermatol. 2014;13(4):414–421. [PubMed] [Google Scholar]
  • 24.Oresajo C, Pillai S, Manco M, Yatskayer M, McDaniel D. Antioxidants and the skin: understanding formulation and efficacy. Dermatol Ther. 2012;25(3):252–259. doi: 10.1111/j.1529-8019.2012.01505.x. [DOI] [PubMed] [Google Scholar]
  • 25.Grether-Beck S, Marini A, Jaenicke T, Krutmann J. Effective photoprotection of human skin against infrared A radiation by topically applied antioxidants: results from a vehicle controlled, double-blind, randomized study. Photochem Photobiol. 2015;91(1):248–250. doi: 10.1111/php.12375. [DOI] [PubMed] [Google Scholar]
  • 26.Pandel R, Poljsak B, Godic A, Dahmane R (2013) Skin photoaging and the role of antioxidants in its prevention. ISRN Dermatology 930164 [DOI] [PMC free article] [PubMed]
  • 27.McDaniel DH, Waugh JM, Jiang LI, et al. Evaluation of the antioxidant capacity and protective effects of a comprehensive topical antioxidant containing water-soluble, enzymatic, and lipid-soluble antioxidants. J Clin Aesthet Dermatol. 2019;12(4):46–53. [PMC free article] [PubMed] [Google Scholar]
  • 28.Valacchi G, Fortino V, Bocci V. The dual action of ozone on the skin. Br J Dermatol. 2005;153(6):1096–1100. doi: 10.1111/j.1365-2133.2005.06939.x. [DOI] [PubMed] [Google Scholar]
  • 29.Valacchi G, Sticozzi C, Pecorelli A, et al. Cutaneous responses to environmental stressors. Ann NY Acad Sci. 2012;1271:75–81. doi: 10.1111/j.1749-6632.2012.06724.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pecorelli A, Woodby B, Prieux R, Valacchi G (2019) Involvement of 4-hydroxy-2-nonenal in pollution-induced skin damage. Biofactors May 14. [Epub ahead of print] [DOI] [PubMed]
  • 31.Valacchi G, Muresan XM, Sticozzi C, et al. Ozone-induced damage in 3D-skin model is prevented by topical vitamin C and vitamin E compound mixtures application. J Dermatol Sci. 2016;82(3):209–212. doi: 10.1016/j.jdermsci.2016.02.007. [DOI] [PubMed] [Google Scholar]
  • 32.Weber D, Milkovic L, Bennett SJ, et al. Measurement of HNE-protein adducts in human plasma and serum by ELISA: comparison of two primary antibodies. Redox Biol. 2013;1:226–233. doi: 10.1016/j.redox.2013.01.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Thiele JJ, Traber MG, Tsang K, Cross CE, Packer L. In vivo exposure to ozone depletes vitamins C and E and induces lipid peroxidation in epidermal layers of murine skin. Free Radic Biol Med. 1997;23(3):385–391. doi: 10.1016/S0891-5849(96)00617-X. [DOI] [PubMed] [Google Scholar]
  • 34.Kousha T, Valacchi G. The air quality health index and emergency department visits for urticaria in Windsor. Canada J Toxicol Environ Health A. 2015;78(8):524–533. doi: 10.1080/15287394.2014.991053. [DOI] [PubMed] [Google Scholar]
  • 35.Valacchi G, Porada E, Rowe BH. Ambient ozone and bacterium Streptococcus: a link between cellulitis and pharyngitis. Int J Occup Med Environ Health. 2015;28(4):771–774. doi: 10.13075/ijomeh.1896.00267. [DOI] [PubMed] [Google Scholar]
  • 36.Xu F, Yan S, Wu M, et al. Ambient ozone pollution as a risk factor for skin disorders. Br J Dermatol. 2011;165(1):224–225. doi: 10.1111/j.1365-2133.2011.10349.x. [DOI] [PubMed] [Google Scholar]
  • 37.Puri P, Nandar SK, Kathuria S, Ramesh V. Effects of air pollution on the skin: a review. Indian J Dermatol Venereol Leprol. 2017;83:415–423. doi: 10.4103/0378-6323.199579. [DOI] [PubMed] [Google Scholar]
  • 38.McDaniel D, Farris P, Valacchi G. Atmospheric skin aging-contributors and inhibitors. J Cosmet Dermatol. 2018;17(2):124–137. doi: 10.1111/jocd.12518. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Dermatological Research are provided here courtesy of Springer

RESOURCES